You are here

  • Home
  • Archive
  • Volume 77, Issue 7
  • ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis

Citation Tools

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Quartier P, Baptiste A, Despert V On behalf of the ADJUVITE Study Group, et al
ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis
Annals of the Rheumatic Diseases 2018;77:1003-1011.